ACADIA Pharmaceuticals
ACAD
$15.10
Share price
0.67%
Change (1 day)
-35.74%
Change (1 year)
Categories
Market capitalization of ACADIA Pharmaceuticals (ACAD)
Market cap: $2.49 Billion
As of June 2024 ACADIA Pharmaceuticals has a market cap of $2.49 Billion. This makes ACADIA Pharmaceuticals the world's 3772th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of ACADIA Pharmaceuticals from 2004 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $2.49 B | -51.47% |
| 2023 | $5.14 B | 99.4% |
| 2022 | $2.57 B | -31.29% |
| 2021 | $3.75 B | -55.85% |
| 2020 | $8.49 B | 27.94% |
| 2019 | $6.64 B | 185.57% |
| 2018 | $2.32 B | -37.8% |
| 2017 | $3.73 B | 7.07% |
| 2016 | $3.49 B | -3.89% |
| 2015 | $3.63 B | 14.41% |
| 2014 | $3.17 B | 39.53% |
| 2013 | $2.27 B | 567.63% |
| 2012 | $0.34 B | 497.99% |
| 2011 | $57.02 M | 20.76% |
| 2010 | $47.22 M | -6.68% |
| 2009 | $50.59 M | 51.22% |
| 2008 | $33.46 M | -91.84% |
| 2007 | $0.40 B | 55.78% |
| 2006 | $0.26 B | 58.61% |
| 2005 | $0.16 B | 45.49% |
| 2004 | $0.11 B |
End of Day market cap according to different sources
On May 31st, 2024 the market cap of ACADIA Pharmaceuticals was reported to be:
$2.49 Billion
$2.49 Billion
$2.49 Billion
$2.49 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $352.98 B | 14,048.73% | 🇺🇸 USA |
 Pfizer PFE | $162.40 B | 6,409.62% | 🇺🇸 USA |
 Eli Lilly LLY | $779.65 B | 31,150.75% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $83.29 B | 3,238.64% | 🇺🇸 USA |
 Vanda Pharmaceuticals VNDA | $0.29 B | -88.08% | 🇺🇸 USA |
 Adamas Pharmaceuticals
ADMS | $0.37 B | -84.91% | 🇺🇸 USA |